Comprehensive bioanalytical laboratory services are critical for drug development. Bioanalytical laboratories are dedicated to delivering robust discovery, preclinical, and clinical testing capabilities. From initial bioanalytical method development through preclinical and clinical bioanalysis, bioanalytics companies have extensive knowledge in conducting and streamlining bioanalytical solutions for most drug development needs.
Reliable bioanalytical service providers have been offering services for analyzing samples in the complex study material. Besides, many bioanalytical laboratories have facilities available at different locations around the globe. Moreover, the team of scientists has extensive experience in complex drug development projects. The current article discusses the importance of analytical lab testing and bioanalytical laboratory services to support drug development.
Bioanalytical laboratory services for drug development
Bioanalytical laboratories focus on technical expertise to deliver high-quality bioanalytical solutions and help drug developers understand and solve experimental challenges. They specialize in delivering bioanalytical services to global markets and help them develop crucial therapy and drug products for the patient population.
Laboratories have in-depth expertise in method development, validation, and transfer, allowing them to offer solutions for challenging endeavors such as rare disease assay development and oncology clinical trials. Besides, they are available to support each pharmaceutical product at every stage of drug development.
Bioanalytical laboratories employ several techniques and platforms to deliver high-quality experimental results. Their expertise includes chromatography, mass spec services, immunohistochemistry, flow cytometry, molecular biology, cell-based assays, etc. Moreover, they offer pharmacology, pharmacokinetics, toxicokinetics, bioequivalence, and bioavailability studies to support drug products from early discovery and preclinical assessments to clinical trials and post-marketing evaluations. Bioanalytical services are committed to providing unique solutions for evaluating drug candidates throughout their entire lifecycle.
Bioanalytical service providers have a team of professionals who can support complex challenges through a network of experts, reliable analytical methodology, standard operating procedures, and rapid lead times. Analytical laboratories have an in-depth understanding of providing support as a drug candidate moves from early discovery and lead optimization studies to nonclinical and clinical assessments via robust logistics, sample collection, and handling experience.
Bioanalytical laboratories such as NorthEast BioAnalytical Laboratories have extensive experience developing, optimizing, validating, and transferring bioanalytical methods to assist compounds in various of biological samples such as serum, plasma, cerebrospinal fluid, tissue, urine, and even unconventional matrices such as bile and muscle. Notably, bioanalytical laboratories are focused on increasing the robustness and efficiency of existing methods, identifying liabilities, and mitigating risks associated with regulatory compliance. Additionally, they are highly focused on the continuous development and validation of newer methods and technology to meet the ever-increasing and volatile demands for developing innovative drug compounds.
Not to mention, bioanalytical laboratories are well-versed in regulated and non-regulated bioanalysis. Non-regulated bioanalytical studies include research-grade assays for small and large molecules such as biosimilars, oligonucleotides, proteins, peptides, anti-drug conjugates, monoclonal antibodies, and vaccines. Besides, their expertise in standard operating protocols compliant with good laboratory practices and current bioanalytical guidance from different regulatory bodies ensures that all regulated bioanalysis provides accurate, reliable, and reproducible results.
